123 related articles for article (PubMed ID: 20848251)
1. Combined antitumor effect of Ad-bFGF-siRNA and Ad-Vpr on the growth of xenograft glioma in nude mouse model.
Zhang B; Feng X; Wang J; Xu X; Lin N; Liu H
Pathol Oncol Res; 2011 Jun; 17(2):237-42. PubMed ID: 20848251
[TBL] [Abstract][Full Text] [Related]
2. [Anti-glioma effect of combination of bFGF-siRNA and Vpr in nude mice].
Feng XQ; Wang JH; Xu XN; Zhang B; Wang SJ; Liu HS; Lin N
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):725-8. PubMed ID: 21163059
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251.
Liu J; Xu X; Feng X; Zhang B; Wang J
J Exp Clin Cancer Res; 2011 Sep; 30(1):80. PubMed ID: 21906308
[TBL] [Abstract][Full Text] [Related]
5. Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway.
Wang Q; Du J; Xu B; Xu L; Wang X; Liu J; Wang J
Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):501-8. PubMed ID: 27189511
[TBL] [Abstract][Full Text] [Related]
6. [Effects of small interfering RNA targeting basic fibroblast growth factor on proliferation and apoptosis of glioma cell line U251].
Wang SJ; Wang JH; Zhang YW; Xu XN; Liu HS
Ai Zheng; 2008 Sep; 27(9):905-9. PubMed ID: 18799025
[TBL] [Abstract][Full Text] [Related]
7. Glioma growth inhibition in vitro and in vivo by single chain variable fragments of the transferrin receptor conjugated to survivin small interfering RNA.
Wang F; Bai HR; Wang J; Bai YZ; Dou CW
J Int Med Res; 2011; 39(5):1701-12. PubMed ID: 22117970
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated delivery of bFGF small interfering RNA increases levels of connexin 43 in the glioma cell line, U251.
Zhang B; Feng X; Wang J; Xu X; Liu H; Lin N
J Exp Clin Cancer Res; 2010 Jan; 29(1):3. PubMed ID: 20074329
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
11. Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886.
Kim SM; Woo JS; Jeong CH; Ryu CH; Lim JY; Jeun SS
Cancer Res; 2012 Sep; 72(18):4807-17. PubMed ID: 22962275
[TBL] [Abstract][Full Text] [Related]
12. [Inhibiting cerebral glioma growth with continuous low-dose chemotherapy and cyclooxygenase-2 inhibitor in nude mice].
Sun JJ; Wang ZY; Liu B; Zhong YF; Du J; Chen YY; Ma CC; Chen XD
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):252-6. PubMed ID: 16778966
[TBL] [Abstract][Full Text] [Related]
13. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
Kaliberova LN; Krendelchtchikova V; Harmon DK; Stockard CR; Petersen AS; Markert JM; Gillespie GY; Grizzle WE; Buchsbaum DJ; Kaliberov SA
Cancer Gene Ther; 2009 Oct; 16(10):794-805. PubMed ID: 19363468
[TBL] [Abstract][Full Text] [Related]
14. [A preliminary study about the apoptostic mechanism of RNA targeting basic fibroblast growth factor in glioma U251 cells].
Wu JC; Feng XQ; Wang JH; Liu J; Zhang B; Xu XN; Liu HS
Zhonghua Wai Ke Za Zhi; 2012 Oct; 50(10):928-32. PubMed ID: 23302466
[TBL] [Abstract][Full Text] [Related]
15. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
Zhang C; Yuan XR; Li HY; Zhao ZJ; Liao YW; Wang XY; Su J; Sang SS; Liu Q
Cell Physiol Biochem; 2015; 35(2):419-32. PubMed ID: 25613036
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Inoue K; Perrotte P; Wood CG; Slaton JW; Sweeney P; Dinney CP
Clin Cancer Res; 2000 Nov; 6(11):4422-31. PubMed ID: 11106263
[TBL] [Abstract][Full Text] [Related]
20. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]